Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project). [PDF]
EClinicalMedicineCoppo P +36 more
europepmc +1 more source
Update on the Laboratory Diagnosis of Lupus Anticoagulant: Current Challenges and Clinical Involvement. [PDF]
J Clin MedMarco-Rico A.
europepmc +1 more source
A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report. [PDF]
Front Med (Lausanne)Huang Y +6 more
europepmc +1 more source
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura. [PDF]
J Clin MedBoothby AB +7 more
europepmc +1 more source
Association between single-nucleotide polymorphisms of ADAMTS13 and severe COVID-19: a case-control study in Chinese Han adults. [PDF]
Arch Med SciTang D, Liu X, He J.
europepmc +1 more source
A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab. [PDF]
Virol JYu B, Zhu Y, Jin Z, Han F, Lv F.
europepmc +1 more source
Exploring Hypercoagulability in Post-COVID Syndrome (PCS): An Attempt at Unraveling the Endothelial Dysfunction. [PDF]
J Clin MedMuys M +4 more
europepmc +1 more source
Single-Nucleotide Polymorphisms in Thrombotic Thrombocytopenic Purpura: A Genetic Predisposition to Immune Thrombotic Thrombocytopenic Purpura. [PDF]
CureusKonopnicki A, Rischall A, Jana B.
europepmc +1 more source